Literature DB >> 28882223

MicroRNAs and Epigenetics.

Catia Moutinho1, Manel Esteller2.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression mainly at the posttranscriptional level. Similar to protein-coding genes, their expression is also controlled by genetic and epigenetic mechanisms. Disruption of these control processes leads to abnormal expression of miRNAs in cancer. In this chapter, we discuss the supportive links between miRNAs and epigenetics in the context of carcinogenesis. miRNAs can be epigenetically regulated by DNA methylation and/or specific histone modifications. However, they can themselves (epi-miRNAs) repress key enzymes that drive epigenetic remodeling and also bind to complementary sequences in gene promoters, recruiting specific protein complexes that modulate chromatin structure and gene expression. All these issues affect the transcriptional landscape of cells. Most important, in the cancer clinical scenario, knowledge about miRNAs epigenetic dysregulation can not only be beneficial as a prognostic biomarker, but can also help in the design of new therapeutic approaches.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Cancer; DNA methylation; Epi-miRNAs; Epigenetics; Histone modifications; MicroRNAs

Mesh:

Substances:

Year:  2017        PMID: 28882223     DOI: 10.1016/bs.acr.2017.06.003

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  25 in total

1.  Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review.

Authors:  Igor Lopes Dos Santos; Karlla Greick Batista Dias Penna; Megmar Aparecida Dos Santos Carneiro; Larisse Silva Dalla Libera; Jéssica Enocencio Porto Ramos; Vera Aparecida Saddi
Journal:  Mol Biol Rep       Date:  2021-02-17       Impact factor: 2.316

2.  Aberrant Methylation of 21 MicroRNA Genes in Breast Cancer: Sets of Genes Associated with Progression and a System of Markers for Predicting Metastasis.

Authors:  V I Loginov; A M Burdennyy; E A Filippova; I V Pronina; S S Lukina; T P Kazubskaya; A V Karpukhin; D S Khodyrev; E A Braga
Journal:  Bull Exp Biol Med       Date:  2021-11-18       Impact factor: 0.804

Review 3.  RNA in cancer.

Authors:  Gregory J Goodall; Vihandha O Wickramasinghe
Journal:  Nat Rev Cancer       Date:  2020-10-20       Impact factor: 60.716

4.  Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2.

Authors:  Soo Mi Lee; Kenneth M Kaye; Frank J Slack
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-09       Impact factor: 11.205

5.  Dietary Restriction and Epigenetics: Part I.

Authors:  Gavin Yong-Quan Ng; David Yang-Wei Fann; Dong-Gyu Jo; Christopher G Sobey; Thiruma V Arumugam
Journal:  Cond Med       Date:  2019-12

6.  Plasma MicroRNAs in Established Rheumatoid Arthritis Relate to Adiposity and Altered Plasma and Skeletal Muscle Cytokine and Metabolic Profiles.

Authors:  Brian J Andonian; Ching-Heng Chou; Olga R Ilkayeva; Timothy R Koves; Margery A Connelly; William E Kraus; Virginia B Kraus; Kim M Huffman
Journal:  Front Immunol       Date:  2019-06-27       Impact factor: 7.561

Review 7.  Epigenetic Biomarkers in Cardiovascular Diseases.

Authors:  Carolina Soler-Botija; Carolina Gálvez-Montón; Antoni Bayés-Genís
Journal:  Front Genet       Date:  2019-10-09       Impact factor: 4.599

Review 8.  Innate Immunomodulation in Food Animals: Evidence for Trained Immunity?

Authors:  Kristen A Byrne; Crystal L Loving; Jodi L McGill
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

Review 9.  Epigenetic and metabolic regulation of epidermal homeostasis.

Authors:  Roland N Wagner; Josefina Piñón Hofbauer; Verena Wally; Barbara Kofler; Matthias Schmuth; Laura De Rosa; Michele De Luca; Johann W Bauer
Journal:  Exp Dermatol       Date:  2021-03-10       Impact factor: 3.960

Review 10.  Involvement of miR-126 in autoimmune disorders.

Authors:  Marco Casciaro; Eleonora Di Salvo; Teresa Brizzi; Carmelo Rodolico; Sebastiano Gangemi
Journal:  Clin Mol Allergy       Date:  2018-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.